Ultime notizie per Arbutus Biopharma (NASDAQ:ABUS) Azioni

Arbutus Biopharma

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma Corp

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>WOLF</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$3.00</td>
<td>$1.0 million</td>
<td>111.7K</td>
<td>45.1K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$157.50</td>
<td>$31.9K</td>
<td>29.1K</td>
<td>27.1K</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$20.00</td>
<td>$191.7K</td>
<td>1.1K</td>
<td>12.0K</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$28.00</td>
<td>$467.1K</td>
<td>4.0K</td>
<td>10.0K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$430.00</td>
<td>$63.2K</td>
<td>21.6K</td>
<td>6.6K</td>
</tr>
<tr>
<td>SOUN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$12.50</td>
<td>$42.6K</td>
<td>3.6K</td>
<td>6.6K</td>
</tr>
<tr>
<td>BBAI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.00</td>
<td>$27.9K</td>
<td>44.4K</td>
<td>3.2K</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$245.00</td>
<td>$25.8K</td>
<td>7.9K</td>
<td>2.3K</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$8.00</td>
<td>$35.5K</td>
<td>14.6K</td>
<td>2.1K</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$380.00</td>
<td>$48.4K</td>
<td>5.6K</td>
<td>1.4K</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For WOLF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>), we notice a put option trade that happens to be bullish, expiring in 10 day(s) on July 18, 2025. This event was a transfer of 10000 contract(s) at a $3.00 strike. The total cost received by the writing party (or parties) was $1.0 million, with a price of $107.0 per contract. There were 111743 open contracts at this strike prior to today, and today 45196 contract(s) were bought and sold. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option trade that happens to be bullish, expiring in 3 day(s) on July 11, 2025. This event was a transfer of 100 contract(s) at a $157.50 strike. The total cost received by the writing party (or parties) was $31.9K, with a price of $319.0 per contract. There were 29148 open contracts at this strike prior to today, and today 27147 contract(s) were bought and sold. 
• Regarding IREN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>), we observe a call option sweep with bullish sentiment. It expires in 255 day(s) on March 20, 2026. Parties traded 498 contract(s) at a $20.00 strike. This particular call needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $191.7K, with a price of $385.0 per contract. There were 1154 open contracts at this strike prior to today, and today 12018 contract(s) were bought and sold. 
• For INTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), we notice a call option sweep that happens to be bearish, expiring in 101 day(s) on October 17, 2025. This event was a transfer of 4366 contract(s) at a $28.00 strike. This particular call needed to be split into 42 different trades to become filled. The total cost received by the writing party (or parties) was $467.1K, with a price of $107.0 per contract. There were 4023 open contracts at this strike prior to today, and today 10062 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a call option sweep that happens to be bullish, expiring in 3 day(s) on July 11, 2025. This event was a transfer of 902 contract(s) at a $430.00 strike. This particular call needed to be split into 28 different trades to become filled. The total cost received by the writing party (or parties) was $63.2K, with a price of $71.0 per contract. There were 21621 open contracts at this strike prior to today, and today 6696 contract(s) were bought and sold. 
• For SOUN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>), we notice a call option trade that happens to be bearish, expiring in 3 day(s) on July 11, 2025. This event was a transfer of 600 contract(s) at a $12.50 strike. The total cost received by the writing party (or parties) was $42.6K, with a price of $71.0 per contract. There were 3619 open contracts at this strike prior to today, and today 6671 contract(s) were bought and sold. 
• Regarding BBAI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>), we observe a call option trade with bearish sentiment. It expires in 192 day(s) on January 16, 2026. Parties traded 130 contract(s) at a $10.00 strike. The total cost received by the writing party (or parties) was $27.9K, with a price of $215.0 per contract. There were 44434 open contracts at this strike prior to today, and today 3280 contract(s) were bought and sold. 
• For ORCL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), we notice a call option sweep that happens to be bearish, expiring in 10 day(s) on July 18, 2025. This event was a transfer of 100 contract(s) at a $245.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $25.8K, with a price of $259.0 per contract. There were 7925 open contracts at this strike prior to today, and today 2377 contract(s) were bought and sold. 
• Regarding CORZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>), we observe a call option trade with bullish sentiment. It expires in 556 day(s) on January 15, 2027. Parties traded 50 contract(s) at a $8.00 strike. The total cost received by the writing party (or parties) was $35.5K, with a price of $710.0 per contract. There were 14611 open contracts at this strike prior to today, and today 2179 contract(s) were bought and sold. 
• Regarding AVGO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), we observe a call option sweep with bullish sentiment. It expires in 164 day(s) on December 19, 2025. Parties traded 85 contract(s) at a $380.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $48.4K, with a price of $570.0 per contract. There were 5633 open contracts at this strike prior to today, and today 1413 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AVGO

BBAI

Core Scientific, Inc. - Class A Common Stock

CORZ

INTC

IREN

MSTR

NVDA

ORCL

SOUN

WOLF

10 Information Technology Stocks With Whale Alerts In Today's Session

Goldman Sachs analyst Duffy Fischer maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Sell and lowers the price target from $13.5 to $12.

News

Price Target

Analyst Ratings

Goldman Sachs Maintains Sell on Huntsman, Lowers Price Target to $12

WIIM

NXPI

NXP Semiconductors shares are trading higher after KeyBanc maintained an Overweight rating and raised the price target from $240 to $275.

Goldman Sachs analyst Joe Ritchie maintains Flowserve (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLS#NYSE">FLS</a>) with a Neutral and raises the price target from $54 to $60.

Goldman Sachs Maintains Neutral on Flowserve, Raises Price Target to $60

Goldman Sachs analyst Adam Bubes maintains EMCOR Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) with a Sell and raises the price target from $384 to $435.

Goldman Sachs Maintains Sell on EMCOR Group, Raises Price Target to $435

Sequans Communications S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>), known for its 5G and IoT chipsets, has raised $384 million in private placements to initiate its <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46201788/public-companies-are-quietly-building-massive-bitcoin-treasuries-faster-than-etfs-can-keep-up">Bitcoin treasury plan</a>.
CEO Georges Karam <a href="https://sequans.com/sequans-closes-384-million-strategic-investment-to-launch-bitcoin-treasury-initiative/">confirmed </a>the firm will deploy net proceeds to purchase Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), part of a broader strategy to fortify financial resilience. 
The funding round consisted of $195 million in PIPE shares and $189 million in convertible debentures maturing in 2028.
The move adds Sequans to the increasingly visible cohort of public companies allocating reserves to Bitcoin. 
Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), the largest corporate Bitcoin holder with 597,325 BTC valued at approximately $64 billion, continues accumulating through equity raises and ATM issuance.
Tesla maintains its Bitcoin holdings, some sold in 2022, but its investment marked early institutional adoption.
Outside the U.S., Japan's Metaplanet (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MTPLF#OTC">MTPLF</a>) aims to hold over 210,000 BTC ($23 billion) by 2027, positioning itself as a corporate Bitcoin treasury firm.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46298615/trump-medias-new-crypto-blue-chip-etf-filing-comes-with-a-twist">Trump Media&#8217;s New &#8216;Crypto Blue Chip ETF&#8217; Filing Comes With A Twist</a>
Canadian fintech Mogo has also approved up to $50 million in Bitcoin allocation, evaluating investment opportunities against a Bitcoin hurdle rate.
Collectively, 116 publicly traded companies now hold Bitcoin on their balance sheets, controlling nearly 730,000 BTC, or around 3.66% of all circulating Bitcoin.
In the first half of 2025 alone, public firms purchased an estimated 131,000 BTC, doubling ETF inflows.
Sequans has tapped U.S. Bitcoin services provider Swan Bitcoin to help manage the acquisition process and governance framework. 
Analysts say the corporate Bitcoin trend is driven by market conditions, inflation hedging, and growing regulatory clarity that legitimizes crypto reserve holdings.
Read Next: 
<ul class="wp-block-list">
<li><a style="font-weight: bold;" href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46297741/robinhoods-openai-space-x-tokens-arent-just-a-gimmick-heres-whats-still-to-come">Robinhood&#8217;s OpenAI, Space X Tokens Aren&#8217;t Just A Gimmick—Here&#8217;s What&#8217;s Still To Come</a></li>
</ul>
Image: Shutterstock

$BTC

MTPLF

SQNS

Sequans Secures $384M To Launch Bitcoin-Focused Treasury Strategy

Goldman Sachs analyst Joe Ritchie maintains Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) with a Buy and raises the price target from $345 to $382.

Goldman Sachs Maintains Buy on Eaton Corp, Raises Price Target to $382

Goldman Sachs analyst Joe Ritchie maintains Allegion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLE#NYSE">ALLE</a>) with a Buy and raises the price target from $149 to $170.

ALLE

Goldman Sachs Maintains Buy on Allegion, Raises Price Target to $170

"Success is not guaranteed," Wall Street Journal reporter Keach Hagey told <a href="https://techcrunch.com/2025/06/01/sam-altman-biographer-keach-hagey-explains-why-the-openai-ceo-was-born-for-this-moment/">TechCrunch in an interview</a> last month. Her recently released biography,<a href="https://www.amazon.com/Optimist-Altman-OpenAI-Invent-Future/dp/1324075961"> "The Optimist</a>," tracks Sam Altman from St. Louis coder to OpenAI CEO.&nbsp;
Hagey warned that Altman's fate depends on "a deal-maker's luck" after a board revolt showed how fragile OpenAI's nonprofit-over-for-profit structure remains.&nbsp;
<h2 class="wp-block-heading">Path From Loopt To OpenAI</h2>
Altman learned to code at age 8 and co-founded the location app Loopt in 2005, selling it for $43.4 million in 2012. He later became president of startup accelerator Y Combinator in 2014, after serving as a part-time partner. While Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) and Stripe had already gone through YC before his presidency, he continued to support startups during their later stages of growth.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
In 2015, Altman co-founded OpenAI as a nonprofit aiming to build safe artificial general intelligence. The lab added a capped-profit arm in 2019 so investors could earn up to 100%,<a href="https://blogs.microsoft.com/blog/2023/01/23/microsoftandopenaiextendpartnership/"> according to Microsoft's 2023 investment blog</a>.&nbsp;&nbsp;&nbsp;
That deal opened a $13 billion pipeline to Microsoft Azure. Hagey said Altman's "once-in-a-generation storytelling" powers kept money flowing while he chased bold research goals.
<h2 class="wp-block-heading">Board Crisis Tests The Charter</h2>
On Nov. 17, 2023, the board removed Altman for not being "consistently candid," an<a href="https://openai.com/index/openai-announces-leadership-transition/"> OpenAI blog post</a> stated.&nbsp;
Within two days, more than 500 employees co-signed a letter threatening to join Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) unless the directors resigned, according to a leaked <a href="https://twitter.com/debarghya_das/status/1726598546223435859">copy on X</a>. By Nov. 20, 2023 the tally hit 700 signatures, pressuring directors to reverse the firing.&nbsp;
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
Altman returned as CEO on Nov. 29, 2023 and a new three-member board — Chair Bret Taylor, former Treasury Secretary Larry Summers, and Adam D'Angelo — took charge, the same <a href="https://openai.com/index/sam-altman-returns-as-ceo-openai-has-a-new-initial-board">blog post</a> confirmed. A later <a href="https://openai.com/index/review-completed-altman-brockman-to-continue-to-lead-openai">review</a> ordered by a special committee found no wrongdoing but urged clearer governance.
Hagey calls the five-day drama "the Blip," saying it proved staff loyalty rests more with Altman's deal skills than the nonprofit mission.
<h2 class="wp-block-heading">New Data Centers Demand Big Cash</h2>
OpenAI now plans to shift its for-profit arm into a public benefit corporation while keeping nonprofit control, an<a href="https://openai.com/index/evolving-our-structure/"> OpenAI structure post</a> reported on May 5. Board chair Taylor said the move balances mission and money. However, the structural change must still be approved by legal authorities in California and Delaware before new investments can flow.
Meanwhile, Altman is securing global capacity. On May 22, Abu Dhabi firm G42 announced<a href="https://www.g42.ai/resources/news/global-tech-alliance-launches-stargate-uae"> Stargate UAE</a>, a 1-gigawatt data center that OpenAI and Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) will run. Oracle <a href="https://www.oracle.com/news/announcement/openai-selects-oracle-cloud-infrastructure-to-extend-microsoft-azure-ai-platform-2024-06-11/">said</a> the company would supply extra cloud power and Nvidia (NVIDIA: NVDA) chips for OpenAI's U.S. builds.&nbsp;
Hagey warned, "Investors will pause until governance and capital match," but she added that Altman "might be up to the challenge."&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence. </a></li>
</ul>
Image: Shutterstock

ABNB

MSFT

'Success Is Not Guaranteed' — Biographer Keach Hagey Says Sam Altman's Future At OpenAI Hangs On A Deal-Maker's Luck And Instability

SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) stock is soaring on Tuesday. However, the stock plunged over 35% year-to-date.
<h2 class="wp-block-heading">What Contributed The Decline</h2>
On February 14, <a target="_blank" href="https://www.benzinga.com/25/02/43739106/soundhound-ai-stock-drops-27-as-nvidia-exits-position" rel="noreferrer noopener">the stock tumbled</a> 27% after Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) disclosed that it had dissolved its stake in the company. Nvidia&#8217;s exit casts doubt on SoundHound AI&#8217;s future growth and stability.
As a key AI player, Nvidia likely gave other investors confidence through its backing.
On March 26, CNBC&#8217;s Jim Cramer recommended selling&nbsp;SoundHound AI, dismissing it as a <a target="_blank" href="https://www.benzinga.com/25/03/44492633/jim-cramer-palantir-is-a-winner-recommends-selling-this-tech-stock" rel="noreferrer noopener">complete meme stock</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/03/44401097/soundhound-ai-integrates-nvidias-software-to-accelerate-voice-ai-technologies" rel="noreferrer noopener">SoundHound AI Integrates NVIDIA&#8217;s Software To Accelerate Voice AI Technologies</a>
Retail investors on social media hype up meme stocks, which often have compelling stories that drive their popularity. GameStop and AMC Entertainment Holdings rank among the most well-known examples.
On May 8, the conversational AI company reported <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45302790/soundhound-ai-stock-slides-on-mixed-q1-results-reaffirms-fy25-outlook" rel="noreferrer noopener">first-quarter revenue</a> of $29.13 million, up 151% year over year, missing analyst&nbsp;estimates&nbsp;of $30.38 million. The stock lost close to 4% in value after the results.
SoundHound AI reaffirmed its full-year 2025 revenue guidance of $157 million-$177 million versus estimates of $166.17 million.
<h2 class="wp-block-heading">Potential Rivals</h2>
As per a June 27 report, Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is exploring acquiring voice-cloning startup PlayAI to strengthen its push into conversational AI and build a superintelligence lab.
Meanwhile, OpenAI enhanced ChatGPT&#8217;s voice assistant in March, making it more natural and engaging as competition in the AI voice space heats up.
Wedbush&#8217;s Daniel Ives expects Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) <a target="_blank" href="https://www.benzinga.com/markets/equities/25/07/46216283/dan-ives-urges-apple-to-make-a-move-saying-that-perplexity-acquisition-is-a-no-brainer-its-a-matter-of-when-and-not-if" rel="noreferrer noopener">to enter the</a> conversational AI space by acquiring Perplexity AI to boost search capabilities and stay competitive.
They urge Apple to move beyond its cautious approach, citing growing pressure from rivals like OpenAI, Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, and Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
<h2 class="wp-block-heading">Analyst Opinion</h2>
Eight analysts have set a <a target="_blank" href="https://www.benzinga.com/quote/SOUN/analyst-ratings" rel="noreferrer noopener">consensus price forecast</a> of $10.50 for SoundHound AI. HC Wainwright gave the highest forecast at $18 on May 12, 2025.
The latest ratings from Piper Sandler (May 27), HC Wainwright &amp; Co. (May 12), and Wedbush (May 9) average a $15 target, suggesting a potential upside of 13.85% for the stock.
H.C. Wainwright&nbsp;analyst&nbsp;Scott Buck noted <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45356352/soundhound-ai-expansion-in-autos-and-dining-plus-q4-profit-target-fuels-bullish-analyst-view" rel="noreferrer noopener">a growing customer base</a> across sectors and 13,000+ restaurant locations as signs of strong business diversification.
According to the analyst, SoundHound AI&#8217;s restaurant segment could generate over $31 million in annual recurring revenue, with room to expand in 2025. He said gross margins will likely improve toward 70% over time despite short-term declines due to recent acquisitions.
Buck added that SoundHound AI&#8217;s $246 million in cash and no debt give the company flexibility for strategic M&amp;A and organic growth opportunities.
Buck now projects SoundHound AI will generate $164 million in revenue for 2025, down from his earlier $170 million estimate but still within the company&#8217;s $157 million–$177 million guidance range.
He forecasts an adjusted EBITDA loss of $50.4 million for the year, including a $0.9 million profit in Q4, marking a key turning point for the business.
For 2026, Buck expects revenue to rise 34.1% to $220 million, with the adjusted EBITDA loss narrowing to $26.1 million. He anticipates greater visibility as the company scales in the coming quarters.
On June 19, Wedbush&#8217;s Dan Ives included SoundHound AI in his new ETF, calling it one of <a target="_blank" href="https://www.benzinga.com/etfs/sector-etfs/25/06/46013679/dan-ives-says-market-is-massively-underestimating-this-ai-play-urges-investors-to-look-beyong-mag-7" rel="noreferrer noopener">the overlooked names</a> poised to benefit from the AI revolution. He noted that investors undervalue AI&#8217;s long-term growth and that focusing only on valuation risks misses transformative tech stocks like SoundHound.
Price Action: SOUN shares traded higher by 13.2% at $12.87 at the last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46292413/alibabas-delivery-ambition-sets-stage-for-chinas-epic-clash-of-giants" target="_blank" rel="noreferrer noopener">Alibaba&#8217;s Delivery Ambition Sets Stage For China&#8217;s Epic Clash Of Giants</a></li>
</ul>
Photo via Shutterstock

Movers

Tech

AAPL

GOOGL

SoundHound AI Plunged 35% In 2025 - Is It Still Worth Owning?

Oppenheimer analyst Owen Lau maintains TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) with a Outperform and raises the price target from $100 to $108.

Oppenheimer Maintains Outperform on TransUnion, Raises Price Target to $108

Canaccord Genuity analyst Sumant Kulkarni maintains Cybin (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CYBN#AMEX">CYBN</a>) with a Buy and lowers the price target from $73 to $70.

CYBN

Canaccord Genuity Maintains Buy on Cybin, Lowers Price Target to $70

Oppenheimer analyst Ari Wald maintains SEI Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEIC#NASDAQ">SEIC</a>) with a Outperform and raises the price target from $96 to $101.

SEIC

Oppenheimer Maintains Outperform on SEI Investments, Raises Price Target to $101

U.S. stocks traded mixed midway through trading, with the Dow Jones index dipping more than 150 points on Tuesday.
The Dow traded down 0.35% to 44,249.09 while the NASDAQ gained 0.07% to 20,427.63. The S&amp;P 500 also fell, dropping, 0.03% to 6,228.39.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46296650/top-2-industrials-stocks-you-may-want-to-dump-this-quarter">Top 2 Industrials Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Energy shares jumped by 2.1% on Tuesday.
In trading on Tuesday, utilities stocks dipped by 1.9%.
Top Headline
The US Manheim Used Vehicle Value Index increased 1.6% month-over-month for June, following a 1.4% decline in May.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>ENDRA Life Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) shares shot up 134% to $8.10 after the company announced it will be granted a US patent titled &#8220;Radio Frequency Applicator&#8221;.</li>
<li>Shares of ProKidney Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) got a boost, surging 218% to $1.95 after the company reported statistically and clinically significant topline results from its Phase 2 REGEN-007 trial evaluating Rilparencel in patients with chronic kidney disease and diabetes.</li>
<li>Humacyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) shares were also up, gaining 20% to $2.5750. Humacyte announced Symvess has been awarded Electronic Catalog Listing approval from the US Defense Logistics Agency.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Blue Gold Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGL#NASDAQ">BGL</a>) shares dropped 21% to $58.75. Blue Gold announced the formation of its inaugural Advisory Board for Blockchain Evolution and named T. Jack Williams as the first member of the Advisory Board.</li>
<li>Shares of Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) were down 11% to $9.84. Solar stocks dropped on Tuesday after President Donald Trump signed an executive order to fast-track the end of clean-energy tax credits late Monday. Keybanc analyst Sophie Karp upgraded Sunrun from Underweight to Sector Weight.</li>
<li>Apogee Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>) was down, falling 8% to $36.24. Apogee Therapeutics recently released 16-week data from Part A of the Phase 2 APEX clinical trial of APG777 for moderate-to-severe atopic dermatitis.</li>
</ul>
Commodities In commodity news, oil traded up 0.3% to $68.14 while gold traded down 1.1% at $3,306.90.
Silver traded down 0.8% to $36.625 on Tuesday, while copper fell 0.5% to $5.0000.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.40%, while Spain's IBEX 35 Index rose 0.10%. London's FTSE 100 gained 0.46%, Germany's DAX 40 gained 0.68% and France's CAC 40 gained 0.46% during the session.
Asia Pacific Markets
Asian markets closed higher on Tuesday, with Japan's Nikkei gaining 0.26%, Hong Kong's Hang Seng climbing 1.09%, China's Shanghai Composite gaining 0.70% and India's BSE Sensex gaining 0.32%.
Economics
<ul class="wp-block-list">
<li>The US Manheim Used Vehicle Value Index increased 1.6% month-over-month for June, following a 1.4% decline in May.</li>
<li>The NFIB Small Business Optimism Index fell to 98.6 in June from 98.8 in May and compared to market estimates of 98.7.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46296955/meta-platforms-to-rally-around-9-here-are-10-top-analyst-forecasts-for-tuesday">Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday</a> </li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

APGE

HUMA

NDRA

PROK

Gold Falls 1%; ProKidney Shares Spike Higher

The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) announced on Tuesday that Kirk Tanner will take over as President and CEO, beginning August 18, marking a significant leadership transition for the company.
Tanner, a seasoned executive in the food and beverage sector, succeeds Michele Buck, who is retiring after a transformative tenure. Buck will remain with the company for a period in an advisory role to support a smooth leadership transition.
The leadership change follows a detailed succession plan, positioning Hershey for sustained growth and innovation under new guidance.
Also Read: <a href="https://www.benzinga.com/25/04/44643347/hershey-expands-snack-empire-with-acquisition-of-lesserevil-for-750m" target="_blank" rel="noreferrer noopener">Hershey Bites Into Better-For-You Snacking With LesserEvil Deal: Details</a>
Tanner currently serves as CEO of The Wendy&#8217;s Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>), where he prioritized brand growth and international expansion. He will depart the <a href="https://www.benzinga.com/pressreleases/25/07/n46294385/wendys-appoints-ken-cook-as-interim-ceo" target="_blank" rel="noreferrer noopener">fast-food chain on July 18, 2025</a>. Wendy&#8217;s CFO Ken Cook has been appointed as interim CEO while the company searches for a permanent replacement.
Tanner also brings more than 30 years of experience from PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>), where he most recently led the $28 billion North American beverage division.
He also held several senior positions, including President of Global Foodservice and VP of Sales for the UK and Ireland. Hershey&#8217;s Board praised Tanner as a strong operator with deep experience in snack foods, beverages, and innovation.
Chair of the CEO Search Committee Mary Kay Haben highlighted Tanner&#8217;s balanced leadership and strategic vision as ideal for driving the company forward. She also thanked Buck for her impactful leadership and for building Hershey&#8217;s status as a multi-category snacking powerhouse.
In a statement, Tanner expressed enthusiasm for leading Hershey, saying the opportunity was &#8220;once-in-a-lifetime.&#8221; He emphasized his commitment to consumers, partners, and employees. Buck also voiced confidence in Tanner, calling it a privilege to support the transition after leading the company through years of sustained growth.
Price Action: HSY shares are trading lower by 2.98% to $170.32&nbsp;at last check Tuesday, while WEN shares are trading lower by 0.13% to $11.29.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/restaurants/25/05/45202730/wendys-mixes-weak-sales-with-a-side-of-resilience-fast-food-restaurant-has-solid-marketing-menu-innovation-plans-says-analyst" target="_blank" rel="noreferrer noopener">Wendy&#8217;s Mixes Weak Sales With A Side Of Resilience: Fast-Food Restaurant Has &#8216;Solid Marketing,&#8217; Menu Innovation Plans, Says Analyst</a></li>
</ul>
Photo via Shutterstock

Topics

General

Hershey Taps PepsiCo And Wendy's Veteran Kirk Tanner As Next CEO

Oppenheimer analyst Jay Olson maintains Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) with a Outperform and raises the price target from $97 to $115.

PRAX

Oppenheimer Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $115

SCCO

Shares of copper stocks are trading higher after President Trump said he believes copper tariffs will be 50%.

Oppenheimer analyst Chad Larkin maintains Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Outperform and raises the price target from $17 to $20.

LYFT

Oppenheimer Maintains Outperform on Lyft, Raises Price Target to $20

Oppenheimer analyst Ian Zaffino maintains Kyndryl Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KD#NYSE">KD</a>) with a Outperform and raises the price target from $47 to $55.

Oppenheimer Maintains Outperform on Kyndryl Hldgs, Raises Price Target to $55

Oppenheimer analyst Owen Lau maintains Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) with a Outperform and raises the price target from $2293 to $2300.

FICO

Oppenheimer Maintains Outperform on Fair Isaac, Raises Price Target to $2300

Press Releases

Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat

Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors

Health Care

Arbutus Provides 2025 Corporate and Financial Update

Management

Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO

Legal

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

Earnings

Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025

Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025

Comments

Arbutus Biopharma

Notizie

Ultime notizie per Arbutus Biopharma (NASDAQ:ABUS) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO